Virginia Retirement Systems
RYTM icon

Virginia Retirement Systems’s Rhythm Pharmaceuticals RYTM Stock Holding History

Virginia Retirement Systems’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$352K Hold
3,700
– – ﹤0.01% 1012
2026
Q2 		$411K Buy
+3,700
New +$335K ﹤0.01% 1026
2026
Q1 		– Sell
-9,200
Closed -$985K – 1046
2025
Q4 		$985K Buy
9,200
+2,500
+37% +$265K 0.01% 585
2025
Q3 		$677K Buy
+6,700
New +$622K ﹤0.01% 693
2023
Q1 		– Sell
-8,000
Closed -$233K – 1207
2022
Q4 		$233K Buy
+8,000
New +$206K ﹤0.01% 1026
2022
Q1 		$136K Buy
+11,800
New +$104K ﹤0.01% 1078

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
iA Global Asset Management
iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return

Virginia Retirement Systems's RYTM Position: Q3 2026 in Review

Virginia Retirement Systems held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 3,700 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Virginia Retirement Systems first reported a position in RYTM in Q1 2022 and has held it in 6 quarters since. The position peaked at $985K in Q4 2025. 59 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Virginia Retirement Systems held 3,700 shares of Rhythm Pharmaceuticals worth $352K as of Q3 2026.
  • Virginia Retirement Systems left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #1012 holding.
  • Virginia Retirement Systems first reported a position in Rhythm Pharmaceuticals in Q1 2022 and has held it in 6 quarters since.
  • Virginia Retirement Systems's Rhythm Pharmaceuticals position peaked at $985K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.